Translational funding opportunities from Cancer Research UK
Application deadline
Applications are reviewed three times per year.
Next EOI deadline: 25 September 2026.
Award volume and duration
up to £250,000, up to 18 months
About the call
Supports collaborative translational cancer drug discovery projects that validate and de-risk promising therapeutic targets and approaches.
Projects are developed with Cancer Research Horizons’ Therapeutic Innovation team and can support a range of therapeutic modalities, including small molecules, antibodies, cell therapies and vaccines.
How to apply
For more info on Expression of Interest (EOI), contact: Claire Heride therapeutic.catalyst@cancer.org.uk
Application deadline
Applications are reviewed twice per year.
Next EOI deadline: October 2026.
Award volume and duration
up to £250,000, up to 18 months
About the call
Supports translational drug discovery projects aimed at developing novel therapeutics for children and young people with cancer. Projects are delivered in collaboration with the Therapeutic Innovation team to validate and de-risk therapeutic opportunities.
How to apply
For more info on Expression of Interest (EOI), contact: therapeutic.catalyst@cancer.org.uk
Application deadline
Applications are reviewed twice per year.
Latest deadline: 21 July 2026
Award volume and duration
Up to £2.5M, up to 5 years
About the call
Supports long-term, integrated programmes of exceptional science that aim to transform how and when early cancers and pre-cancerous states are detected and diagnosed.
How to apply
For more info contact early.detection@cancer.org.uk